-
GINKGO BIOWORKS HOLDINGS INC NEW YORK STOCK EXCHANGE INC.:DNA Ginkgo Bioworks is building a platform to enable customers to program cells as easily as they can program computers. The company's cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.
Location: | Website: www.ginkgobioworks.com | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
359.5M
Cash
616.2M
Avg Qtr Burn
-83.75M
Short % of Float
22.20%
Insider Ownership
6.16%
Institutional Own.
68.39%
Qtr Updated
09/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|